Design and synthesis of a NAD(P)H:quinone oxidoreductase 1-activatable photosensitiser for controlled photodynamic therapy
Chemical Communications · 2023
DOI: 10.1039/d3cc00683b ↗At a glance
Journal article in Chemical Communications, 2023. Written by Evelyn Y Xue and 3 co-authors. Institution: Department of Chemistry, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China. dkpn@cuhk.edu.hk. Major MEDLINE topics: Photosensitizing Agents, Photochemotherapy. Cited 16 times so far (Crossref); 33 references. Funded by: Research Grants Council, University Grants Committee.
Abstract (original language)
A far-red-absorbing photosensitiser that can be activated by human NAD(P)H:quinone oxidoreductase 1 has been designed, synthesised and examined for its in vitro and in vivo responsive properties.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Chemistry, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China. dkpn@cuhk.edu.hk.
Funding
- Research Grants Council, University Grants Committee
Cite
APA
Xue, E. Y., Kang, F., Zhou, Y., & Ng, D. K. P. (2023). Design and synthesis of a NAD(P)H:quinone oxidoreductase 1-activatable photosensitiser for controlled photodynamic therapy. Chemical Communications. https://doi.org/10.1039/d3cc00683b
Vancouver
Xue EY, Kang F, Zhou Y, Ng DKP. Design and synthesis of a NAD(P)H:quinone oxidoreductase 1-activatable photosensitiser for controlled photodynamic therapy. Chemical Communications. 2023. doi:10.1039/d3cc00683b
BibTeX
@article{Xue2023,
author = {Xue, Evelyn Y and Kang, Fangyuan and Zhou, Yimin and Ng, Dennis K P},
title = {Design and synthesis of a NAD(P)H:quinone oxidoreductase 1-activatable photosensitiser for controlled photodynamic therapy},
journal = {Chemical Communications},
year = {2023},
doi = {10.1039/d3cc00683b}
}
EUVIMED